Company news

Double Bond Pharmaceutical International AB news in 2026

Double Bond Pharmaceutical International AB's news releases, calls and decks from 2026, newest first.

View company

DBP.B: Q1 2026 delivered narrowed losses and major clinical validation for Temodex

May 22, 2026

DBP.B: Equity restored and net loss reduced as SI-053 development progressed, but funding needs persist

February 26, 2026